The U.S. Food and Drug Administration has approved a drug to treat neuroblastoma, an often-fatal pediatric cancer, based on pioneering research by College of Human Medicine professor André Bachmann. The FDA approved a tablet form of a drug called difluoromethylornithine, or DFMO (synonym eflornithine), developed in 1978 and later used to treat West African sleeping …
This year’s theme “Map Your Mind” gave young learners an opportunity to learn how the brain works through interactive stations, brain games and presentations by the medical students. Parents attended workshops with community leaders and health professionals. Building a pathway to medicine Reach Out to Youth is hosted by the college’s Student National Medical Association …
The assistant professor Carolina de Aguiar Ferreira has the resources at Michigan State University to precisely target cancer cells with diagnostics and therapies using radioisotopes produced by what is designed to be the world’s most powerful heavy-ion accelerator. She works in the highly collaborative Institute for Quantitative Health Science and Engineering, or IQ, and the …
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer. Their weapon of choice? A drug-like compound named Ogremorphin, or OGM. In laboratory experiments, OGM showed a remarkable ability to kill glioblastoma cells while leaving normal cells unharmed. …
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer. Their weapon of choice? A drug-like compound named Ogremorphin, or OGM. In laboratory experiments, OGM showed a remarkable ability to kill glioblastoma cells while leaving normal cells unharmed. …
“As a Parkinson’s disease neurobiologist, I am trying to uncover causes of Parkinson’s as well as potential treatments to slow or halt the disease,” says Caryl E. Sortwell, Ph.D., Professor of Translational Neuroscience, Department of Translational Neuroscience, in the MSU College of Human Medicine. She also studies ways to optimize the efficacy of therapies that …
Coming home was never part of his plan. Yet here is Detroit native Charles (aka “Chaz”) Hong, after earning multiple degrees from MIT and Yale and teaching medicine at Harvard, Vanderbilt, and the University of Maryland, back in Michigan as chair of the College of Human Medicine’s Department of Medicine. “I never imagined I’d be …
Jayne Ward, DO, FACH, FAAN, has been appointed chair of the Department of Neurology and Ophthalmology, a department shared by the College of Osteopathic Medicine and the College of Human Medicine. Dr. Ward has served as director of the neurology residency, a professor in the department, and director of the National Multiple Sclerosis Clinic …
The Michigan State University Board of Trustees today approved six new departments in the MSU College of Human Medicine. The departments – dermatology, otolaryngology, pathology, radiation oncology, urology, and neurosurgery – are being developed as part of the Henry Ford Health + Michigan State University Health Sciences partnership. By creating the six departments, MSU is fulfilling …
A new statewide center led by researchers at Henry Ford Health + Michigan State University Health Sciences and Corewell Health will study ways to reduce an alarming number of pregnancy-associated deaths and complications, particularly among Black, Hispanic and rural residents. The Multilevel Interventions to Advance Maternal Health Equity Center, or MIRACLE, is one of 10 …
